STAT3 upregulates miR-92a to inhibit RECK expression and to promote invasiveness of lung cancer cells

Microarray Analysis of Colorectal Cancer Stromal Tissue Reveals Upregulation of Two Oncogenic miRNA Clusters

(2012) N. Nishida et al.   CLINICAL CANCER RESEARCH

Increased miR-222 inH. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK

(2012) Na Li et al.   FEBS LETTERS

Keratinization-associated miR-7 and miR-21 Regulate Tumor Suppressor Reversion-inducing Cysteine-rich Protein with Kazal Motifs (RECK) in Oral Cancer

(2012) Hyun Min Jung et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Small Molecule Inhibitors of Signal Transducer and Activator of Transcription 3 (Stat3) Protein

(2012) Bikash Debnath et al.   JOURNAL OF MEDICINAL CHEMISTRY

Oncogenic miRNA-182-5p Targets Smad4 and RECK in Human Bladder Cancer

(2012) Hiroshi Hirata et al.   PLoS One

miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer

(2011) Akihiko Tsuchida et al.   CANCER SCIENCE

MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma

(2011) Bjørn Helge Haug et al.   CARCINOGENESIS

Current prospects for RNA interference-based therapies

(2011) Beverly L. Davidson et al.   NATURE REVIEWS GENETICS

Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells

(2011) L Y W Bourguignon et al.   ONCOGENE

What we learn from transformation suppressor genes: lessons fromRECK

(2010) Makoto Noda et al.   Future Oncology

STAT3 Activation of miR-21 and miR-181b-1 via PTEN and CYLD Are Part of the Epigenetic Switch Linking Inflammation to Cancer

(2010) Dimitrios Iliopoulos et al.   MOLECULAR CELL

Hypoxia and RAS-signaling pathways converge on and cooperatively downregulate, the RECK tumor-suppressor protein through microRNAs

(2010) F Loayza-Puch et al.   ONCOGENE

Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development

(2010) Masatoshi Shigoka et al.   PATHOLOGY INTERNATIONAL

Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia

(2010) Shuangli Mi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Interleukin-6 Modulates the Expression of the Bone Morphogenic Protein Receptor Type II Through a Novel STAT3–microRNA Cluster 17/92 Pathway

(2009) Matthias Brock et al.   CIRCULATION RESEARCH

Elevated Expression of the miR-17–92 Polycistron and miR-21 in Hepadnavirus-Associated Hepatocellular Carcinoma Contributes to the Malignant Phenotype

(2008) Erin Connolly et al.   AMERICAN JOURNAL OF PATHOLOGY

Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells

(2008) Shu Takakura et al.   CANCER SCIENCE

Targeted Deletion Reveals Essential and Overlapping Functions of the miR-17∼92 Family of miRNA Clusters

(2008) Andrea Ventura et al.   CELL

Overexpression of Jab1 in Hepatocellular Carcinoma and Its Inhibition by Peroxisome Proliferator-Activated Receptor  Ligands In vitro and In vivo

(2008) M.-C. Hsu et al.   CLINICAL CANCER RESEARCH

Homeodomain-interacting protein kinases (Hipks) promote Wnt/Wg signaling through stabilization of  -catenin/Arm and stimulation of target gene expression

(2008) W. Lee et al.   DEVELOPMENT

MicroRNA Expression and Regulation in Mouse Uterus during Embryo Implantation

(2008) Shi-Jun Hu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

An Array-Based Analysis of MicroRNA Expression Comparing Matched Frozen and Formalin-Fixed Paraffin-Embedded Human Tissue Samples

(2008) Xiao Zhang et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators

(2008) G. Gabriely et al.   MOLECULAR AND CELLULAR BIOLOGY

The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition

(2008) Nicole Cloonan et al.   GENOME BIOLOGY